Effective Viral Vector SARS ‐CoV‐2 Booster Vaccination in a Patient with Rheumatoid Arthritis after Initial Ineffective mRNA Vaccine Response

AbstractManaging patients with rheumatic disease during the COVID-19 pandemic has posed a unique challenge. Immunosuppressed patients are at an increased risk for developing severe COVID-19 and may not derive full protection from the vaccine (1-5). Thus, it is paramount we develop strategies whereby rheumatic disease patients can be protected from the pandemic virus and its variants.

https://onlinelibrary.wiley.com/doi/10.1002/art.41978?af=R

Source: Arthritis and Rheumatology - September 13, 2021 Category: Rheumatology Authors: Matthew C. Baker, Vamsee Mallajosyula, Mark M. Davis, Scott D. Boyd, Kari C. Nadeau, William H. Robinson Tags: LETTER TO THE EDITOR Source Type: research